These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2126497)

  • 1. Colony-stimulating factors in parasitic diseases.
    Reed SG
    Diagn Microbiol Infect Dis; 1990; 13(5):387-9. PubMed ID: 2126497
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trials of myeloid growth factors.
    Glaspy JA; Golde DW
    Exp Hematol; 1990 Nov; 18(10):1137-41. PubMed ID: 1698650
    [No Abstract]   [Full Text] [Related]  

  • 3. GM-CSF produced by recombinant vaccinia virus or in GM-CSF transgenic mice has no effect in vivo on murine cutaneous leishmaniasis.
    Corcoran LM; Metcalf D; Edwards SJ; Handman E
    J Parasitol; 1988 Oct; 74(5):763-7. PubMed ID: 3047351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The myeloid colony-stimulating factors: introduction and overview.
    Peters WP
    Semin Hematol; 1991 Apr; 28(2 Suppl 2):1-5. PubMed ID: 1712123
    [No Abstract]   [Full Text] [Related]  

  • 5. Application of recombinant granulocyte-macrophage colony-stimulating factor has a detrimental effect in experimental murine leishmaniasis.
    Greil J; Bodendorfer B; Röllinghoff M; Solbach W
    Eur J Immunol; 1988 Oct; 18(10):1527-33. PubMed ID: 3142778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colony-stimulating factors: clinical status.
    Gabrilove JL
    Important Adv Oncol; 1991; ():215-37. PubMed ID: 1714420
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-infectious responses in Leishmania major-infected BALB/c mice injected with recombinant granulocyte-macrophage colony-stimulating factor.
    Solbach W; Greil J; Röllinghoff M
    Ann Inst Pasteur Immunol; 1987; 138(5):759-62. PubMed ID: 3326625
    [No Abstract]   [Full Text] [Related]  

  • 8. Granulocyte/macrophage colony stimulating factor. A potent activation signal for mature macrophages and monocytes.
    Morrissey PJ; Grabstein KH; Reed SG; Conlon PJ
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):40-5. PubMed ID: 2496041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow-derived macrophages grown in GM-CSF or M-CSF differ in their ability to produce IL-12 and to induce IFN-gamma production after stimulation with Trypanosoma cruzi antigens.
    Tadokoro CE; de Almeida Abrahamsohn I
    Immunol Lett; 2001 May; 77(1):31-8. PubMed ID: 11348667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant granulocyte-macrophage colony-stimulating factor restores deficient immune responses in mice with chronic Trypanosoma cruzi infections.
    Reed SG; Grabstein KH; Pihl DL; Morrissey PJ
    J Immunol; 1990 Sep; 145(5):1564-70. PubMed ID: 2117033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow failure and hematopoietic growth factors.
    Douer D
    Isr J Med Sci; 1989 Apr; 25(4):183-5. PubMed ID: 2468629
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical applications of myeloid colony stimulating factors.
    Steward WP; Thatcher N; Kaye SB
    Cancer Treat Rev; 1990 Mar; 17(1):77-87. PubMed ID: 1699660
    [No Abstract]   [Full Text] [Related]  

  • 13. Leishmania sp: comparative study with Toxoplasma gondii and Trypanosoma cruzi in their ability to initialize IL-12 and IFN-gamma synthesis.
    Oliveira MA; Santiago HC; Lisboa CR; Ceravollo IP; Trinchieri G; Gazzinelli RT; Vieira LQ
    Exp Parasitol; 2000 Jun; 95(2):96-105. PubMed ID: 10910710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte-macrophage and macrophage colony-stimulating factors activate intramacrophage killing of Leishmania mexicana amazonensis.
    Ho JL; Reed SG; Wick EA; Giordano M
    J Infect Dis; 1990 Jul; 162(1):224-30. PubMed ID: 2113077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion of immunoregulatory macrophages by granulocyte-macrophage colony-stimulating factor derived from a murine mammary tumor.
    Fu YX; Watson G; Jimenez JJ; Wang Y; Lopez DM
    Cancer Res; 1990 Jan; 50(2):227-34. PubMed ID: 2136804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical application of hematopoietic growth factor (IL-3, G-CSF, GM-CSF, and EPO)].
    Motoyoshi K
    Nihon Rinsho; 1992 Aug; 50(8):1967-72. PubMed ID: 1279240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of hematopoietic growth factors in the treatment of neoplastic diseases.
    St Onge J; Jacobson RJ
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):53-63. PubMed ID: 1380737
    [No Abstract]   [Full Text] [Related]  

  • 18. [Expectations in the clinical application of human-recombinant cytokines. 4) Interleukin-3 and colony-stimulation factors].
    Takaku F
    Nihon Rinsho; 1988 May; 46(5):1105-11. PubMed ID: 2457722
    [No Abstract]   [Full Text] [Related]  

  • 19. Intracellular destruction of Leishmania tropica by macrophages activated with macrophage activating factor/interferon.
    Titus RG; Kelso A; Louis JA
    Clin Exp Immunol; 1984 Jan; 55(1):157-65. PubMed ID: 6198115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunobiology of hematopoietic colony-stimulating factors: potential application to disease prevention in the bovine.
    Kehrli ME; Cullor JS; Nickerson SC
    J Dairy Sci; 1991 Dec; 74(12):4399-412. PubMed ID: 1724001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.